Almost a yr in the past, Merck struck a $10.8 billion deal to accumulate Prometheus Biosciences, a clinical-stage firm whose know-how platform analyzed genetic and organic information to find new medicine. The chief who led Prometheus to that acquisition is now again with a brand new immunology startup backed by $400 million. Mirador Therapeutics launched Thursday, aiming to use the […]
